Verve Therapeutics, Inc. VERV
11.13 0.00 (+0.00%)
At closeJul 25, 2025, 4:00 PM EDT
11.13 Day range 11.13
52-week range unavailable
- YTD
- +97.34%
- 1 year
- +57.20%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 32.33M | 11.76M | 1.94M | 0 | 0 | |
| 32.33M | 11.76M | 1.94M | 0 | 0 | |
| -228.66M | -223.12M | -165.69M | -87.07M | -40.63M | |
| -198.71M | -200.07M | -157.39M | -120.31M | -45.70M | |
| -2.35 | -3.12 | -2.91 | -4.48 | -20.31 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 177.33M | 210.95M | 120.24M | 69.57M | 9.46M | |
| 647.39M | 752.69M | 679.22M | 384.12M | 78.41M | |
| 153.99M | 153.19M | 128.29M | 26.77M | 17.16M | |
| 59.54M | 74.91M | 70.01M | 0 | 0 | |
| 493.40M | 599.50M | 550.93M | 357.35M | -63.91M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -157.69M | -149.55M | -122.33M | -77.88M | -35.27M | |
| 74.88M | 27.69M | -155.96M | -239.10M | -51.13M | |
| 49.20M | 212.58M | 328.96M | 377.09M | 92.63M | |
| -3.74M | -9.28M | -13.23M | -4.36M | -3.42M | |
| -33.62M | 90.72M | 50.67M | 60.11M | 6.24M |